Frontlight ResearchEarly access
Congenital heart disease trials in Ireland
1 trial · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in IrelandFollow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
- Where
- Dublin
- Age
- 3 months to 80 years
- People
- 50 worldwide
- Run by
- Occlutech International AB
See details and how to joinNCT05329350